Multi-center trial of ziprasidone (Geodon) augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder

Trial Profile

Multi-center trial of ziprasidone (Geodon) augmentation in serotonin reuptake inhibitor-resistant obsessive-compulsive disorder

Not stated
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 08 Sep 2006

At a glance

  • Drugs Ziprasidone (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Sep 2006 The expected completion date for this trial is now 14 Mar 2004.
    • 08 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top